Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
Anvisa · 13 medicines
PHARMAC · 6 medicines
CBG-MEB · 4 medicines
AIFA · 3 medicines
AEMPS · 1 medicine
MS · 1 medicine · Historical list
Every register, a page at a time. Strengths and packs are on each medicine’s page.
18 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Clonidine | United States | 0.1MG/24HR, 0.2MG/24HR, 0.3MG/24HR | system | Marketed | Actavis Labs Ut INC |
| Clonidine | United States | 0.09MG BASE/ML | suspension, extended release | Not marketed | Tris Pharma INC |
| Clonidine Hydrochloride | United States | 0.1MG, 0.2MG | tablet, extended release | Marketed | Novast Labs |
| Clonidine Hydrochloride | United States | 1MG/10ML, 5MG/10ML | injectable | Marketed | Fresenius Kabi USA |
| Clonidine Hydrochloride | United States | 0.05MG, 0.1MG, 0.2MG … | tablet | Marketed | Watson Labs |
| Clonidine Hydrochloride and ChlorthalidoneCombination | United States | 15MG; 0.1MG, 15MG; 0.2MG, 15MG; 0.3MG | tablet | Not marketed | Par Pharm |
| Duraclon | United States | 1MG/10ML, 5MG/10ML (0.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable | Marketed | Mylan Institutional |
| Nexiclon XR | United States | 0.17MG BASE, 0.26MG BASE | tablet, extended release | Marketed | Rosemont |
| Catapres-TTS-1 | United States | 0.1MG/24HR | system | Marketed | Lavipharm |
| Catapres-TTS-2 | United States | 0.2MG/24HR | system | Marketed | Lavipharm |
| Catapres-TTS-3 | United States | 0.3MG/24HR | system | Marketed | Lavipharm |
| Onyda XR | United States | 0.1MG/ML | suspension, extended release | Marketed | Tris Pharma INC |
| Javadin | United States | 0.02MG/ML | solution | Marketed | Azurity |
| Catapres | United States | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Boehringer Ingelheim |
| Jenloga | United States | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet, extended release | Not marketed | Concordia Pharms INC |
| Kapvay | United States | 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet, extended release | Not marketed | Concordia Pharms INC |
| ClorpresCombination | United States | 15MG; 0.1MG, 15MG; 0.2MG, 15MG; 0.3MG | tablet | Not marketed | Natco Pharma |
| CombipresCombination | United States | 15MG; 0.1MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 15MG; 0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 15MG; 0.3MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Boehringer Ingelheim |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, Anvisa, CBG-MEB, FDA, Health Canada, MS and PHARMAC. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
